title: Treatment of genital lichen sclerosus in women--review.
abstract: Lichen sclerosus is a chronic inflammatory skin disorder that belongs to a group of autoimmune connective tissue diseases, localized within the skin and mucous membrane of the anogenital area. In the latter location, the focal atrophy of the mucosa is the most visible sign. Lesions may be accompanied by symptoms such as itching, pain, burning. The disease occurs more often in females. The etiology is not fully understood. Genetic, infectious, hormonal factors and autoimmune mechanisms are taken into consideration. Early diagnosis and appropriate treatment is important to avoid further complications. This review aims to analyze available literature on the treatment of this disease entity
authors.affiliation: Department of Dermatology, Poznan University of Medical Sciences, Poland. a.sadowska80@gmail.com
authors.forename: Anna
authors.initials: A
authors.lastname: Sadowska-Przytocka
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Dańczak-Pazdrowska
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Szewczyk
authors.forename: Magdalena
authors.initials: M
authors.lastname: Czarnecka-Operacz
authors.forename: Dorota
authors.initials: D
authors.lastname: Jenerowicz
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Osmola-Mańkowska
authors.forename: Karolina
authors.initials: K
authors.lastname: Olek-Hrab
mesh_terms: D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018459:Lichen Sclerosus et Atrophicus / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D007724:Vulvar Lichen Sclerosus / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents